News
-
-
COMMUNIQUÉ DE PRESSE
BB BIOTECH AG: Creating blockbuster drugs using algorithms
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: BB Biotech AG publishes its interim report
-
COMMUNIQUÉ DE PRESSE
BB BIOTECH AG: Lackluster first quarter for biotech stocks
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: BB Biotech AG publishes its 2022 annual report
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: BB Biotech AG closes the 2022 fiscal year with a loss
-